News

Back to All News

Lake Street serves as financial advisor for Aquestive Therapeutics, Inc. (NasdaqGM:AQST) in its initial public offering of 4,500,000 shares of common stock.

July 25, 2018

Lake Street is pleased to announce it served as a financial advisor for Aquestive Therapeutics, Inc. (NasdaqGM: AQST) in its initial public offering of 4,500,000 shares of common stock at a public offering price of $15.00 per share for gross proceeds of $67,500,000.

About Aquestive Therapeutics, Inc.

Aquestive Therapeutics is a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products to address unmet medical needs. Aquestive Therapeutics has a late-stage proprietary product pipeline focused on the treatment of CNS diseases, and is working to advance orally-administered complex molecules that it believes can be alternatives to invasively-administered standard of care therapies. As the leader in developing and delivering drugs via its PharmFilm® technology, Aquestive Therapeutics also collaborates with pharmaceutical partners to bring new molecules to market in differentiated and highly-marketable dosage forms.

Contact Us

Phone
612.326.1305

US Mail
920 Second Avenue South
Suite 700
Minneapolis, MN 55402

Email
Email Us

Find Us